NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Clinical trial NCT06452394 · RECRUITING
Trial details
- NCT number
- NCT06452394
- Sponsor
- Swiss Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2028-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.